NOT FOR DISTRIBUTION

Market Cap

CN¥6.6b

Last Updated

2021/05/17 09:47 UTC

Data Sources

Company Financials

Executive Summary

Zhongjin Irradiation Incorporated Company provides irradiation services in China. More Details


Snowflake Analysis

Excellent balance sheet with questionable track record.


Similar Companies

Share Price & News

How has Zhongjin Irradiation's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine 300962's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine 300962's volatility change over the past year.


Market Performance


7 Day Return

5.2%

300962

10.1%

CN Life Sciences

3.2%

CN Market


1 Year Return

n/a

300962

97.7%

CN Life Sciences

26.0%

CN Market

Return vs Industry: Insufficient data to determine how 300962 performed against the CN Life Sciences industry.

Return vs Market: Insufficient data to determine how 300962 performed against the CN Market.


Shareholder returns

300962IndustryMarket
7 Day5.2%10.1%3.2%
30 Day-17.1%18.8%3.6%
90 Dayn/a-5.8%-5.1%
1 Yearn/a98.3%97.7%27.9%26.0%
3 Yearn/a289.3%285.3%27.6%21.6%
5 Yearn/a252.9%247.5%37.2%28.3%

Long-Term Price Volatility Vs. Market

How volatile is Zhongjin Irradiation's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Zhongjin Irradiation undervalued compared to its fair value and its price relative to the market?

70.22x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 300962 (CN¥26.48) is trading above our estimate of fair value (CN¥18.38)

Significantly Below Fair Value: 300962 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 300962 is poor value based on its PE Ratio (70.2x) compared to the CN Life Sciences industry average (66.8x).

PE vs Market: 300962 is poor value based on its PE Ratio (70.2x) compared to the CN market (30.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 300962's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 300962 is overvalued based on its PB Ratio (8.5x) compared to the CN Life Sciences industry average (7.6x).


Future Growth

How is Zhongjin Irradiation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.7%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zhongjin Irradiation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Zhongjin Irradiation performed over the past 5 years?

38.4%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: 300962 has high quality earnings.

Growing Profit Margin: 300962's current net profit margins (29%) are higher than last year (23.3%).


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if 300962's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare 300962's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.

Earnings vs Industry: 300962 earnings growth over the past year (38.4%) underperformed the Life Sciences industry 109.6%.


Return on Equity

High ROE: 300962's Return on Equity (9.7%) is considered low.


Financial Health

How is Zhongjin Irradiation's financial position?


Financial Position Analysis

Short Term Liabilities: 300962's short term assets (CN¥306.1M) exceed its short term liabilities (CN¥54.9M).

Long Term Liabilities: 300962's short term assets (CN¥306.1M) exceed its long term liabilities (CN¥54.0M).


Debt to Equity History and Analysis

Debt Level: 300962's debt to equity ratio (3.5%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 300962's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 300962's debt is well covered by operating cash flow (537.3%).

Interest Coverage: 300962's interest payments on its debt are well covered by EBIT (31x coverage).


Balance Sheet


Dividend

What is Zhongjin Irradiation current dividend yield, its reliability and sustainability?

0.60%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 300962's dividend (0.6%) is higher than the bottom 25% of dividend payers in the CN market (0.47%).

High Dividend: 300962's dividend (0.6%) is low compared to the top 25% of dividend payers in the CN market (1.86%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether 300962's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 300962's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (42.4%), 300962's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Zhongjin Irradiation has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: 300962 only recently listed within the past 12 months.


Top Shareholders

Company Information

Zhongjin Irradiation Incorporated Company's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Zhongjin Irradiation Incorporated Company
  • Ticker: 300962
  • Exchange: SZSE
  • Founded: 2003
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥6.645b
  • Shares outstanding: 264.00m
  • Website: https://www.zjfzgroup.com

Number of Employees


Location

  • Zhongjin Irradiation Incorporated Company
  • China Dongsheng Road 68
  • Luohu District
  • Shenzhen
  • Guangdong Province
  • China

Listings


Biography

Zhongjin Irradiation Incorporated Company provides irradiation services in China. It offers radiation processing services, such as medical product sterilization, food preservation, chemical materials modif...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/17 09:47
End of Day Share Price2021/05/17 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.